title: Hallucinations with therapeutic doses of clarithromycin.
abstract: OBJECTIVE
  Hallucinations caused by adverse reactions to medication are not uncommon and a wide variety of drugs may be involved. We present a case of hallucinations caused by therapeutic doses of oral clarithromycin (500 mg b.i.d).
  
  
  METHODS
  A 32-year-old woman attended the Emergency Department of the hospital with severe visual hallucinations together with marked anxiety and nervousness following the second dose of clarithromycin, which was the only medication she was taking. The antibiotic was identified as the possible cause of the clinical manifestations and was stopped immediately. The patient did not require hospitalization and was discharged a few hours later with no signs of neurological disturbances. Clarithromycin was substituted by amoxycillin-clavulanic acid (500/125 mg) t.i.d.
  
  
  CONCLUSIONS
  The temporal relationship between commencement of antibiotic therapy and the appearance of hallucinations, together with the fact that the symptoms disappeared once the antibiotic was suspended, support a causal relationship between clarithromycin and the hallucinations. Further support for a causal relationship was obtained by application of Naranjo's algorithm which gave a likelihood level for causality of PROBABLE.
authors.affiliation: Pharmacy Service, Hospital General Universitario de Elche, Elche/Alicante, Spain.
authors.lastname: Jiménez-Pulido
authors.forename: A
authors.initials: A
authors.lastname: Navarro-Ruiz
authors.forename: P
authors.initials: P
authors.lastname: Sendra
authors.forename: M
authors.initials: M
authors.lastname: Martínez-Ramírez
authors.forename: C
authors.initials: C
authors.lastname: Garcia-Motos
authors.forename: A
authors.initials: A
authors.lastname: Montesinos-Ros
mesh_terms: D000328:Adult; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001007:Anxiety / Q000139:chemically induced; D017291:Clarithromycin / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D004244:Dizziness / Q000139:chemically induced; D005260:Female; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D019980:Amoxicillin-Potassium Clavulanate Combination; D017291:Clarithromycin